You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4826 to 4850 of about 5861
Next 25
04/30/2005
4/22/05 Exhibit highlighting people affected by brain tumors coming to State House - Display begins April 28, in time for Brain Tumor Awareness Week
Antisense Pharma Completes Patient Recruitment for AP 12009 Phase II Trial
Study Comparing Radiation Therapy and Surgery for Acoustic Neuroma Patients Urged
04/26/2005
The Neuro-Tribune: newsletter of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center
Added Link to: Brainhelp
Added Link to: Our Angel Maureen
Added Link to: OSCAR (UK) - you already have this listed but it is not connecting when selected.
Updated George`s survivor story
Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Updated Shannon`s Survivor Story!
HEALTH CARE ADVOCATE COMMEMORATES NATIONAL BRAIN TUMOR AWARENESS WEEK
~~~Together in Hope: A Conference for Brain Tumor Patients and their Families~~~
European Union`s CHMP Recommends Approval of TEMODAL(R) (Temozolomide) for the Most Common and Aggressive Form of Brain Cancer
Minds Over Matter Sag Harbor (NY) 5 K Run
04/19/2005
MRI predicts cancer treatment efficacy
New Data Presented at AACR Meeting Support the Clinical Potential of Semafore`s Novel PI3K Prodrug
New Medicare Rules For PET Scans For Brain Tumors
Improving malignant glioma survival rates
Four Leading Brain Philanthropies Announce Pioneering Collaboration - 2005 Awards to Focus on New Technologies to Cross the Blood-Brain Barrier and to Target Specific Regions in the Brain
04/18/2005
Spectrum Pharmaceuticals Presents Data on EOquin(TM) as a Radiation Sensitizer at the Annual Meeting of American Association of Cancer Research (AACR) in Anaheim, California
Call for Participants: MALIGNANT BRAIN TUMOR SYMPTOMS STUDY
Scientist works to reduce side effects of radiation therapy
Hana Biosciences to Present Positive Pre-Clinical Data on IPdR at AACR Meeting - Pre-clinical study shows IPdR demonstrates effective dose-responsive radiotherapy sensitization and direct inhibition of human gliobastoma tumors in xenografts